Login / Signup
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment.
Tsen Fang Tsai
Published in:
The British journal of dermatology (2020)
Keyphrases
</>
ankylosing spondylitis
rheumatoid arthritis
replacement therapy